Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form − 5 Years Follow-Up

The literature review we conducted reveals the limited use of proprotein convertase subtilisin/kexin type 9-inhibitors (PCSK9i) in children with familial hypercholesterolemia (FH). In 2015, a 10-year-old boy presented with round, xanthochromic lesions on his right knee and elbow. The values of total...

Descripción completa

Detalles Bibliográficos
Autores principales: Vladimirova-Kitova, Lyudmila, Kitov, Spas, Ganev, Mihail, Chochkova-Bukova, Lubov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531482/
https://www.ncbi.nlm.nih.gov/pubmed/34692794
http://dx.doi.org/10.3389/fcvm.2021.743341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531482/
https://www.ncbi.nlm.nih.gov/pubmed/34692794
http://dx.doi.org/10.3389/fcvm.2021.743341

Ejemplares similares